JamesEGalvinMDMPH

PubMed

• 98 citations
  The neurotoxicity of DOPAL: behavioral and stereological evidence for its role in Parkinson disease pathogenesis.
  W. Michael Panneton, Vijaya B. Kumar, Qi Gan, William J. Burke, James E. Galvin
  Plos One. 2010-12-13
• 1957 citations
  Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
  Ian G. McKeith, Bradley F. Boeve, Dennis W. Dickson, Glenda M. Halliday, John-Paul Taylor
  Neurology. 2017-07-04
• 381 citations
  DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
  Carol F. Lippa, John E. Duda, Murray Grossman, Howard I. Hurtig, Dag Aarsland
  Neurology. 2007-03-13

Journal Articles

• DOPAL, the MAO Metabolite of Dopamine is Responsible for Dopamine Neuron Loss and Triggers ?-Synuclein Aggregation in vitro.  
  Burke WJ, Kumar VB, Pandey N, Franko MW, O’Dell M, Chung HD, and Galvin JE, Acta Neuropathologica
• Relationship of Cytotoxic Activity of Natural Killer Cells to Growth and Serum Zinc Levels of Female RIII Mice Fed Zinc.  
  Bunk MJ, Galvin JE, Yung YP, Dnistrian AM, and Blaner WS, Nutr Can
• Increased Vulnerability of NFH-LacZ Transgenic Mouse to Traumatic Brain Injury-Induced Behavioral Deficits and Cortical Damage.  
  84. Nakamura M, Saatman KE, Galvin JE, Scherbel U, Raghupathi R, Trojanowski JQ, McIntosh TK, J Cereb Blood Flow Metab
• Pathobiology of the Lewy Body: Studies with Purified Lewy Bodies, Monoclonal Antibodies and LB-like Inclusions in Transgenic Animal Models.  
  Galvin JE, Lee VM-Y, Schmidt ML, Tu PH, Iwatsubo T, and Trojanowski JQ, Adv Neurol
• Alpha-synuclein Cortical Lewy Bodies are Markers for Dementia.  
  Hurtig HI, Trojanowski JQ, Galvin JE, Ewbank D, Schmidt ML, Lee VM-Y, Clark CM, Glosser G, Stern MB, Gollomp SM, and Arnold SE, Neurology
• Gene Expression Profiling the Neuropathology of Neurodegenerative Disease.  
  Galvin JE, Neurochem Res
• Clinicopathologic correlates in Familial Dementia with Lewy Bodies.  
  Galvin JE, Lee SL, Perry A, Havioglu N, McKeel DW, and Morris JC, Dementia
• Mild cognitive impairment represents early Alzheimer’s disease.  
  Galvin JE, Palmer JL, and Morris JC, Research Prac Alz Dis
• Neuromorphometric Predictors of Response to Donepezil in Dementia of the Alzheimer Type.  
  Csernansky JG, Wang L, Miller JP, Galvin JE, and Morris JC, Arch Neurol
• Alzheimer’s Disease: Diagnosis and Treatment Across the Spectrum.  
  Galvin JE, App Neurol
• Effect of a ?-secretase inhibitor on Alpha and cognition in patients with Alzheimer’s disease.  
  Siemers ER, Quinn JF, Kaye J, Farlow MR, Porsteinsson A, Tariot P, Zoulnouni P, Galvin JE, Holtzman DM, Knopman DS, Satterwhite J, Dean R, May PC, Neurology
• Diagnosing and managing Alzheimer’s disease in the family practice setting.  
  Alva G, Borson S, Fillit H, Galvin JE, Sloane PD, and Tangalos EG, Fam Pract Recertif
• Predictors of preclinical Alzheimer disease.  
  Galvin JE, Powlishta KK, Wilkins K, McKeel Jr DW, Xiong C, Grant E, Storandt M, and Morris JC, Research Prac Alz Dis
• Development of a Behavioral Model to Study the Intention of Older Adults to Undergo Cognitive Screening For Dementia Diagnosis.  
  Galvin JE, Scharff D, Glasheen C, and Fu JQ, Alz Dis Assoc Disord
• DLB and PDD Working Group Symposium: Boundary Issues and Future Priorities.  
  Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz C..., Neurology
• Alzheimer Disease: Understanding the Challenges, Improving the Outcome.  
  Galvin JE, App Neurol
• Mild Physical Impairment Predicts Future Diagnosis of Dementia of the Alzheimer Type.  
  Wilkins CH, Roe CM, Morris JC, and Galvin JE, J Am Geratric Soc
• Attention Deficits in Alzheimer’s Disease: Two Head-to-Head Studies of Galantamine and Donepezil.  
  Galvin JE, Cornblatt B, Newhouse P, Ancoli-Israel, Wesnes K, Williamson D, Zhu Y, Sorra K, Amatniek J, Alz Dis Assoc Disord
• Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.  
  Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, and Nessly ML, Neurology
• Treatment with Donepezil Does Not Alter Longitudinal Hippocampal Surface Changes In Mild Alzheimer Disease.  
  Wang L, Harms MP, Stags J, Xiong C, Morris JC, Csernansky JG, Galvin JE, Arch Neurol
• Visuospatial Ability in Relation to Fall Risk and Dementia – In Reply.  
  Galvin JE, Johnson DK, Arch Neurol
• A multi-center, randomized, double-blind, placebo-controlled trial of simvastatin to slow the progression of Alzheimer’s disease.  
  Sano M, Bell K, Galasko D, Galvin JE, Thomas RG, van Dyck CH, and Aisen P, Neurology
• Should prevalence prevail when considering screening tests? The case for targeted screening with informant based instruments.  
  Galvin JE, Morris JC, Brain
• Ordering of Alzheimer Disease Biomarkers.  
  Glodzik L, Galvin J, Pirralgia E, and de Leon M, Arch Neurol
• Medical Foods and Nutritional Approaches in the Treatment of Alzheimer Disease.  
  Thaipisuttikul P and Galvin JE, Clinical Practice
• Join now to see all

Books/Book Chapters

• Clinical Features and Pathogenesis of Dementia with Lewy Bodies and Parkinson’s Disease. 
  Chapter: Neurobiology Of Mental Illness 
  Karantzoulis S and Galvin JEEditors: Charney D, Buxbaum J, Sklar P, Nestler E.Oxford University Press
• Mental Status Examination in the Geriatric Patient. 
  Chapter: Geriatric Neurology 
  Thaipisuttikul P, Galvin JEEditors: Sabbagh M, Nair A.Prentice Hall, Upper Saddle River
• Alzheimer’s Disease. 
  Chapter: Pathy's Principles And Practice Of Geriatric Medicine 
  Galvin JEEditors: Sinclair A, Vellas B, Morley J.Wiley-Blackwell, New YorkEdition 5,
• Neurological Signs in Old Age. 
  Chapter: Brocklehurst’s Textbook Of Geriatrics And Clinical Gerontology 
  Tarawneh R, Galvin JEEditors: Fillit H, Rockwood K, Woodhouse K.Elsevier, PhiladelphiaEdition 7,
• Dementia with Lewy Bodies and Other Synucleinopathies. 
  Chapter: Clinical Manual For Alzheimer Disease And Other dementias 
  Galvin JEEditors: Weiner M, Lipton A.American Psychiatric Publishing, Inc., Washington
• Mental Status and Neurologic Examination. 
  Galvin JE
• Mental Status and Neurologic Examination. 
  Chapter: Hazzard's Principles Of Geriatric Medicine And Gerontology 
  Galvin JEEditors: Halter JB, Asthana,S, High K, Studenski S, Ouslander J, Tinetti, M.McGraw-Hill, New YorkEdition 6,
• Dementia with Lewy bodies and other synucleinopathies. 
  Chapter: Textbook Of Alzheimer’s And Dementia 
  Tarawneh R, Galvin JEEditors: Weiner M, Lipton A.American Psychiatric Publishing, Inc., New York
• Parkinson’s Disease and Dementia with Lewy Bodies. 
  Chapter: Handbook Of Dementing Illnesses 
  Galvin JEEditors: Morris JC, Galvin JE, Holtzman DM.Taylor-Francis, New YorkEdition 2,
• The Cellular and Molecular Pathology of Parkinson’s Disease. 
  Chapter: Neurodegenerative Dementias: Clinical Features And Pathological Mechanisms 
  Giasson BI, Galvin JE, Lee VM-Y, and Trojanowski JQEditors: Clark CM, Trojanowski JQ.McGraw-Hill, New York
• Mechanisms of Neuron Death in Neurodegenerative Diseases of the Elderly: The Role of the Lewy Body. 
  Chapter: Handbook Of The Aging Brain 
  Trojanowski JQ, Galvin JE, Schmidt ML, Tu PH, Iwatsubo T, and Lee VM-YEditors: Wang E, Snyder SD.Academic Press, Orlando
• Handbook Of Dementing Illnesses. 
  Morris JC, Galvin JE, Holtzman DMEditors: Morris JC, Galvin JE, Holtzman DM.Taylor-Francis, New YorkEdition 2,
• Alzheimer’s diseases. 
  Turkington C and Galvin JEFacts on File, New York
• Join now to see all

Lectures

• Action of Growth Hormone on Rates of Lipolysis and Lipoprotein Lipase Activity in Adipose Tissue of White Leghorn Chickens in vitro. 
  Master’s Thesis, Rutgers University, New Brunswick, NJ